Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-19-039326

Options or other derivatives

  • Director acquired 234,407 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sigal Charles Elliott Director 2019-07-02 Grant or award · Option to purchase Ordinary Shares +234,407 234,407 D: show line 1 in the form
Loading xslF345X03/a4.xml…